Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-524 (miR-524, hsa-miR-524) is a short non-coding RNA molecule (microRNA) that regulates gene expression post-transcriptionally by binding to target mRNAs and promoting their degradation or inhibiting their translation. It is transcribed as part of a longer RNA precursor and then processed to its mature, functional form. MiR-524-5p plays a role in suppressing tumor cell proliferation, migration, and invasion in multiple cancers by targeting key components of signaling pathways such as MAPK/ERK (notably BRAF and ERK2) and Notch (via NUMB). It acts as a tumor suppressor in glioma and melanoma, and its downregulation is associated with poorer outcomes and higher tumor grade in glioma. The molecule shows context-dependent functions: it is downregulated in some cancers (glioma, thyroid cancer) where it suppresses tumor progression, but upregulated in others (osteosarcoma) where it can promote cell proliferation. MiR-524-5p is being explored as both a therapeutic candidate and a prognostic biomarker, particularly in brain tumors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-524 (miR-524).